Theravance Biopharma Inc
Theravance Biopharma Inc is a biopharmaceutical company focused on bringing novel therapies to patients.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Theravance Biopharma's stock, expecting it to rise to $16.5.
Financial Health
Theravance Biopharma shows modest revenue and cash flow, indicating stable, but not exceptional financial health.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring TBPH
Beyond The Patent Cliff: Pharma's New Growth Engines
AbbVie raised its profit outlook, proving it can thrive after its blockbuster Humira faced competition. This creates an investment opportunity in resilient pharmaceutical companies that are successfully launching new drugs to replace older ones.
Published: August 1, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Pipeline Catalysts
Clinical readouts and regulatory milestones can move the stock significantly, though outcomes are uncertain and may change investor expectations quickly.
Commercial Progress
Market uptake of any approved products and the strength of partner collaborations influence revenue, but commercial execution and competition are risks to monitor.
Partnering & Royalties
Collaborations and royalty streams can help fund development and de‑risk programmes, yet they depend on partners' performance and can produce irregular income.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
